Treatment

Xarelto 15 mg film-coated tablets clinical trials

2 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic use (Phase IV)
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
This study looks at how well different blood thinners work to prevent strokes in people who've had a procedure called 'catheter ablation' for a wobbly heart rhythm (atrial fibrillation). It aims to find the best way to stop strokes while keeping side effects low.
For: Risk of stroke by Atrial Fibrillation
Germany · Belgium
Ongoing, recruitingTherapeutic use (Phase IV)
COmparison of Bleeding Risk between Rivaroxaban and Apixaban for the treatment of acute venous thromboembolism
This study compares two common blood-thinning medicines, Rivaroxaban (Xarelto) and Apixaban (Eliquis), for treating blood clots (venous thromboembolism). Researchers want to see which medicine causes fewer serious bleeding side effects for patients already on these treatments.
For: Acute Venous Thromboembolism
Ireland